BTCC / BTCC Square / Global Cryptocurrency /
Rubicon Research Shares Surge 28% in Strong Market Debut

Rubicon Research Shares Surge 28% in Strong Market Debut

Published:
2025-10-16 09:39:01
8
2
BTCCSquare news:

Rubicon Research Ltd made a striking market entrance, with shares opening 27.85% above their IPO price of ₹485 on the BSE. The pharmaceutical firm's stock debuted at ₹620.10, reflecting robust investor confidence after its oversubscribed ₹1,377.5-crore offering.

The company's valuation now stands at ₹9,917.97 crore, fueled by a 103.9-times subscription rate. Proceeds will primarily service debt and fund strategic acquisitions, aligning with Rubicon's expansion in regulated markets like the US.

June's acquisition of Alkem Laboratories' facility signals aggressive manufacturing capacity growth. The OFS component saw promoter General Atlantic Singapore RR Pte Ltd divest ₹877.5 crore worth of shares.

|Square

Get the BTCC app to start your crypto journey

Get started today Scan to join our 100M+ users

All articles reposted on this platform are sourced from public networks and are intended solely for the purpose of disseminating industry information. They do not represent any official stance of BTCC. All intellectual property rights belong to their original authors. If you believe any content infringes upon your rights or is suspected of copyright violation, please contact us at [email protected]. We will address the matter promptly and in accordance with applicable laws.BTCC makes no explicit or implied warranties regarding the accuracy, timeliness, or completeness of the republished information and assumes no direct or indirect liability for any consequences arising from reliance on such content. All materials are provided for industry research reference only and shall not be construed as investment, legal, or business advice. BTCC bears no legal responsibility for any actions taken based on the content provided herein.